zepbound and tirzepatide Now Available Through LillyDirect: A New Option for Access at a Predictable Price FDA approval for Zepbound: FSU

1 But they have also proven to be effective in helping people lose weight, and three GLP-1 drugs Wegovy, Zepbound, and Saxenda have FDA approval to be used for chronic weight management

Devices such as Sofwave, UltraClear, and Pure Impact can start during weight loss

GLP-1 medications reduce hunger, which can deepen the restrictive eating patterns of disorders like anorexia and have been linked to relapses in case reports

BMJ Open Diabetes Res Care (2021) 9(1):e002300

In late April 2025, the FDA issued a key update regarding the use of compounded GLP-1 receptor agonists like semaglutide and tirzepatide

Key highlights The time of day you take semaglutide does not affect how quickly you lose weight